Would Wider Access to GLP-1s Throttle Addiction?
Cato Daily Podcast
00:00
Understanding Drug Compounding and Its Impact on GLP-1 Access
This chapter delves into the drug compounding process for GLP-1 medications, focusing on how pharmacists tailor treatments for patients facing challenges with standard forms. It underscores the regulatory landscape guiding compounding practices and emphasizes its role in enhancing medication accessibility and affordability.
Transcript
Play full episode
